Next Article in Journal
Experimental Study of Thermomechanical Processes: Laser Welding and Melting of a Powder Bed
Previous Article in Journal
Late Age Dynamic Strength of High-Volume Fly Ash Concrete with Nano-Silica and Polypropylene Fibres
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Crystals
Volume 10
Issue 4
10.3390/cryst10040245
crystals-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Synthesis, Crystal Structure and Bioactivities of N-(5-(4-chlorobenzyl)-1,3,5-Triazinan-2-Ylidene)Nitramide

by
Yao-Guo Qin
1,2,
Zhao-Kai Yang
2,
Jia Fan
1,*,
Xin Jiang
1,
Xin-Ling Yang
2,* and
Ju-Lian Chen
1,*
1
State Key Laboratory for Biology of Plant Diseases and Insect Pests, Institute of Plant Protection, Chinese Academy of Agricultural Sciences, Beijing 100193, China
2
Department of Applied Chemistry, College of Science, China Agricultural University, Beijing 100193, China
*
Authors to whom correspondence should be addressed.
Crystals 2020, 10(4), 245; https://doi.org/10.3390/cryst10040245
Submission received: 27 January 2020 / Revised: 21 March 2020 / Accepted: 24 March 2020 / Published: 26 March 2020
Browse Figures
Versions Notes

Abstract

:
The compound N-(5-(4-chlorobenzyl)-1,3,5-triazinan-2-ylidene)nitramide (C10H12ClN5O2, M = 269.70) was synthesized and structurally confirmed by 1H NMR, 13C NMR, HRMS and single-crystal x-ray diffraction. The crystal belongs to the monoclinic system with space group P21/c. The title compound consisted of a benzene ring and a 1,3,5-triazine ring. All carbon atoms in the benzene ring were nearly coplanar with a dihedral (C6–C5–C10 and C7–C8–C9) angle of 1.71°and all non-hydrogen atoms of the 1,3,5-triazine ring were not planar, but exhibited a half-chair conformation. The crystal structure was stabilized by a strong intramolecular hydrogen bonding interaction N(3)–H(3)···O(2) and three intermolecular hydrogen bonding interactions, N(2)–H(2)···O(1), N(2)–H(2)···N(4) and N(3)–H(3)···Cl(1). The preliminary bioassay showed that the title compound showed not only aphicidal activity against Sitobion miscanthi (inhibition rate: 74.1%) and Schizaphis graminum (77.5%), but also antifungal activities against Pythium aphanidermatum (62.0%). These results provide valuable guidelines for the design and synthesis of novel aphid control agents and fungicides.

Graphical Abstract

1. Introduction

Substituted triazine compounds have attracted more and more attention in recent years for their use as medicines [1,2,3] and agrochemicals [4,5,6], such as adenosine A antagonists, anticonvulsants, antimicrobials, anticancer agents, bactericides, herbicides and insecticides. Among these triazines, hexahydro-1,3,5-triazine, is endowed with simple structure and very important pharmaceutical activities, such as insecticidal [7], antifungal [8], herbicidal [9] and antiviral [10] activities. In addition, the electron-withdrawing group of NO2 plays a crucial role in providing insecticidal properties [11], such as those against Myzus persicae [12], Aphis gossypi [13], Aphis medicagini [14], Nilaparvata lugens [15] and Spodoptera littoralis [16]. Besides, benzyl groups exhibited outstanding activities, such as in insecticidal activity of Pyridaben and fungicidal activity of Cyflufenamid. However, during the past decade, resistance and cross-resistance have increased in a range of species due to their frequent applications in field [17,18,19,20].
As part of our ongoing work in exploring triazine active chemical structures, we noticed that a type of 2-nitroimino-hexahydro-1,3,5-triazine (NHT) derivatives displayed biological activity against the apterous adult aphids of M. persicae [21,22] and Acyrthosiphon pisum [23]. In the view of these facts and in order to further search for NHT derivatives with high bioactivity and broad-spectrum, the titled compound N-(5-(4-chlorobenzyl)-1,3,5-triazinan-2-ylidene)nitramide (1), was designed by introducing benzyl group active substructure into NHT scaffold. The Compound 1 was synthesized through combining nitro guanidine, formaldehyde and 4-chlorobenzylamine via the Mannich reaction using the one-pot method in protic solvent (Scheme 1). The structure of the corresponding compound was characterized by 1H NMR, 13C NMR, HRMS and single-crystal x-ray diffraction. Furthermore, the insecticidal activity against different aphid species was evaluated. Moreover, compounds containing NHT group have been discovered to showed antifungal activity [24,25,26]. Herein, we have also estimated the antifungal activity of Compound 1.

2. Materials and Methods

2.1. General Techniques

Melting point of the Compound 1 was determined on an X-5 binocular (Fukai Instrument Co., Beijing, China) with an uncorrected thermometer. 1H NMR spectra were measured on a Bruker DPX300 spectrometer (Bruker, Bremen, Germany). Chemical shifts were reported in δ (ppm) with TMS as the internal standard and DMSO-d6 as the solvent. 13C-NMR spectra were obtained by using a Bruker DPX300 spectrometer (75 MHz) with DMSO-d6 as a solvent. The chemical shifts (δ) were reported in parts per million using the solvent peak. High-resolution mass spectral data were acquired by a FTICR-MS Varian 7.0 T FTICR-MS instrument (Varian, Palo Alto, CA). A single-crystal x-ray structure was recorded on a Gemini E x-ray single crystal diffractometer (Rigaku, Tokyo, Japan). Nitro guanidine, formaldehyde and 4-chlorobenzylamine were purchased from Beijing Ouhe Technology Co., Ltd. (Beijing, China). All the other reagents were acquired from Sinopharm Chemical Reagent Co., Ltd. (Beijing, China) and used without further purification.

2.2. Synthesis of N-(5-(4- Chlorobenzyl)-1,3,5-Triazinan-2-Ylidene)Nitramide

The target Compound 1 was prepared according to a modified procedure based on the published methods [27]. The synthetic approach of Compound 1 is shown in Scheme 1. To a solution of 4-chlorobenzylamine (58 mmol) and nitro guanidine (48 mmol) in ethanol (20 mL), 37% formaldehyde (120 mmol) was added dropwise. The reaction mixture was stirred at 60 °C for 6 h. After it was cooled to room temperature, the mixture was filtered and the filtrate was washed with cold ethanol and acetone, respectively, then dried under infrared lamp to obtain the white solid Compound 1 with a yield of 65.3%. m.p.: 201–203 °C. 1H NMR (DMSO-d6, 300 MHz), δ(ppm): 8.79 (brs, 2H, NH), 7.34–7.40 (m, 4H, ArH), 4.24 (s, 4H, CH2), 3.78 (s, 2H, Ar-CH2). 13C NMR (DMSO-d6, 75 MHz), δ(ppm): 155.80, 136.70, 132.15, 130.69, 128.44, 59.58, 53.25. HRMS calculated for C10H12ClN5O2 (M+H)+: 270.0752, found 270.0747.

2.3. Structure Determination

Single crystals suitable for x-ray diffraction were obtained from slow evaporation of a solution of the title compound 1 in dichloromethane/petroleum ester (v/v = 3/1) at temperature of 4 °C. Compound 1 exists in the form of colorless crystals. A crystal of Compound 1 (0.36 mm × 0.20 mm × 0.14 mm) was selected for data collection and mounted in inert oil, which was transferred to the cold gas stream of the Gemini E x-ray single crystal diffractometer (Rigaku, Tokyo, Japan) equipped with a graphite-monochromatic μMoKα radiation (λ = 0. 0.71073 Å) at temperature 109(10) K. In a range of 6.59 < 2θ < 58.972°, a total of 9949 reflections were collected by using an ω scan mode, of which 3246 were unique with Rint = 0.0332 and 2794 were observed with I > 2σ(I). The structure of Compound 1 was solved via Direct Methods and the solutions were refined by full-matrix least squares techniques on F2 by SHELXL-2014 program [28]. All non-hydrogen atoms were refined anisotropically; the hydrogen atoms were located theoretically. The final R = 0.0468, wR = 0.0864 (w = 1/[σ2(Fo2) + (0.0311P)2], where P = (Fo2+ 2Fc2)/3), S = 1.066, (△/σ)max = 0.859, (△σ)max = 0.291 and (△/σ)min = −0.288 e/Å3 included 169 parameters. Crystal data and structure refinement data of Compound 1 are shown in Table 1.

2.4. Aphicidal Activity

The in vivo aphicidal activities of Compound 1 against Myzus persicae, Sitobion miscanthi, Rhopalosiphum padi, Schizaphis graminum and Metopolophium dirhodum were measured using the reported method [29,30]. Compound 1 was dissolved in DMSO to a concentration of 2000 mg/L and then diluted to 200 mg/L with 0.05% Triton X-20. Wheat seedlings (for wheat aphids) or cabbage leaf discs (for M. persicae) were dipped into the test solution for 15 s. And then, the seedlings or discs were infested with 20 ± 3 apterous adult aphids and incubated under constant temperature (25 ± 1 °C) and light period (light : dark = 8:16) for 48 h. The number of dead aphids was then recorded, and the inhibition rates were corrected using Abbott’s formula [31]. Each experiment was conducted in triplicates. The LC50 values were also determined based on the preliminary aphid mortality rates. The commercial insecticide Pymetrozine was used as a positive control while the solvent was set as a negative control.

2.5. Antifungal Activity

The in vitro antifungal activities of the Compound 1 were evaluated against six plant fungal pathogens (Rhizoctonia solani, Pythium aphanidermatum, Valsa mali, Botrytis cirerea, Fusarium moniliforme, Alternaria solani). The mycelium growth rate method was used according to references [32,33]. Compound 1 was dissolved in DMSO to prepare the 10 mg/mL stock solution, then mixed with PDA (Potato Dextrose Agar) medium to a concentration of 50 mg/L and was poured into sterilized Petri dishes. After the dishes were cooled, the mycelia disks were inoculated in the center of the Petri dishes and incubated at 25 °C. Each experiment was repeated three times. After 2–3 d of culturing, the colony diameter of each strain was measured. The commercial fungicide, Difenoconazole, with broad spectrum against fungus was used as the positive controls.

3. Results and Discussion

3.1. Crystal Structure

The title Compound 1 crystallized in the monoclinic system. The molecular structure of the Compound 1 is depicted in Figure 1. Selected molecular structure parameters, including bond lengths, bond angles and torsion angles of Compound 1 are summarized in Table 2 and Supplementary Materials Table S1, S2 and S3. Other parameters of fractional atomic coordinates (×104) and equivalent isotropic displacement parameters (Å2 × 103), anisotropic displacement parameters (Å2 × 103), hydrogen atom coordinates (Å × 104) and isotropic displacement parameters (Å2 × 103) are listed in Supplementary Materials Table S4, S5 and S6. The Hydrogen bonds and crystal packing of Compound 1 are displayed in Figure 2. The molecule crystal structure of Compound 1 had been deposited in the Cambridge Crystallographic Data Centre; the recorded CCDC number was 1,973,548. Crystallographic data for Compound 1 can be obtained free of charge at the following website: http://www.ccdc.cam.ac.uk/data_request/cif.
As shown in Table 2, all bond lengths and angles are generally within normal ranges and in a good agreement with those reported previously [34,35,36,37,38,39,40]. The C–C bond lengths of benzene ranged from 1.380(2) to 1.396(2) Å, which were extremely close to C–C bond lengths (1.373(3) to 1.393(2) Å) of benzene in compound (E)-5-benzyl-1-methyl-N-nitro-1,3,5-triazinan-2-imine [34]. In the 1,3,5-triazine ring (C1/C2/C3/N3/N2—N1), four of the six amino C–N bonds were shortened equivalent C–N single bond (1.49 Å) [41]. The bond lengths of N(2)–C(2), N(3)–C(3), N(1)–C(2) and N(1)–C(3) were 1.4743(19) Å, 1.472(2) Å, 1.4476(18) Å and 1.4453(19) Å, respectively. The remaining two amino bonds N(2)–C(1) [1.3310(19) Å] and N(3)–C(1) [1.3277(19) Å] were equivalent partial double bonds [37], shorten than that of N(2)–C(2), N(3)–C(3), N(1)–C(2) and N(1)–C(3), which suggested that the electron density of the imino C(1)–N(4) bond p-electrons was delocalized among N(2)–C(1)–N(4) and N(3). This phenomenon also existed in other crystal structures bearing NHT ring, such as (E)-5-benzyl-1-methyl-N-nitro-1,3,5-triazinan-2-imine [34], 1,5-dimethyl-2-nitroimino-1,3,5-triazinane [35], 1-(2-chloro-1,3-thiazol-5-ylmethyl)-3,5-dimethyl-2-nitrimino-1,2,3,4,5,6-hexahydro-1,3,5-triazine [36] and 2-nitrimino-5-nitro-hexahydro-1,3,5-triazine [37]. The length of the imino bond C(1)=N(4) was 1.3707(19) Å, which was significantly longer than above two amino bonds N(2)–C(1) and N(3)–C(1) in the 1,3,5-triazine ring. The distances of resemble guanidine structures with nitro group were found in literatures with similar values from 1.342 to 1.389 Å [34,35,36,37,41,42]. However, these distance values were longer than those of reported C=N bonds with nitro group with values between 1.267 and 1.275 Å [43,44,45,46,47]. Bracuti commented molecular interaction and intermolecular H-bonds in crystal structure had responsibilities for this elongation of hydrazine C=N bond [37]. Meanwhile, the length of nitrimino bond N(4)–N(5) (1.3405(17) Å), a partial double bond, was similar with reported nitrimino bond distance (1.322–1.362 Å) [34,35,37,41]. In particular, it was similar with the distance of nitrimino bond in 1,5-dimethyl-2-nitroimino-1,3,5-triazinane, regardless of trans and cis configuration [35]. But it was longer than the length of nitrimino bond (1.294 Å) in 1-(2-chloro-1,3-thiazol-5-ylmethyl)-3,5-dimethyl-2-nitrimino-1,2,3,4,5,6-hexahydro-1,3,5-triazine [36]. The Cl(1)–C(8) bond length was 1.7538(15) Å, which corresponds to typical values for the C(sp2)–Cl bond length.
The title compound consisted of a benzene ring and a 1,3,5-triazine ring. All carbon atoms in the benzene ring were nearly coplanar with a dihedral (C6–C5–C10 and C7–C8–C9) angle of 1.71°and all non-hydrogen atoms of the 1,3,5-triazine ring were not planar, but exhibited a half-chair conformation. This half-chair conformation could be also found in some crystal structures with 1,3,5-triazine ring, such as in structures of CCDC codes 859,274 [48], 840,152 [42], 774,302 [34], 700,528 [35], 674,453 [36] and 224906 [37]. On the other side, the conformation of 1,3,5-triazine ring in other compounds presented different. For instance, those conformations from structures of CCDC codes 842,778 [49], 957,651 [50] were not half-chair, but planar. The 1,3,5-triazine ring in Compound 1 displayed a large distortion due to the nature of its non-conjugated system. For example, the torsion angels of C(2)–N(2)–C(1)–N(3), C(2)–N(1)–C(3)–N(3) and C(1)–N(3)–C(3)–N(1) were 6.7(2)˚, 58.45(15)˚ and –35.90(18)˚, respectively. The 1,3,5-triazine ring formed two planes C3/C2/N2/C1/N3 and N1/C3/C2, respectively, with a dihedral angle of 49.08° between them. The atoms N(2)–C(1)–N(4) and N(3) were nearly planar. The bond angles of N(1)–C(4)–C(5), C(3)–N(1)–C(2) and N(3)–C(1)–N(2) were 111.81(12)˚, 108.67(12)˚ and 119.06(14)˚, respectively. The N atom in the nitro group and C atom in the Schiff base were nearly coplanar, with a torsion of –3.4(2)˚ for C(1)–N(4)–N(5)–O(2).
The hydrogen bonds and crystal packing characteristics of Compound 1 in the unit cell are described in Figure 2. Analysis of the crystal packing indicates that molecules were linked by the intermolecular and intramolecular interactions. An intramolecular N–H⋅⋅⋅O hydrogen bonding interaction occurred, resulting in the formation of a six-membered nearly planar ring (N(3)/H(3)/O(2)/N(5)/N(4)/C(1)). In the crystal structure, molecules were stabilized by intermolecular N–H⋅⋅⋅N, N–H⋅⋅⋅O and N–H⋅⋅⋅Cl hydrogen bonding interactions, forming a S-shaped chain along the c axis. The distances between donor (D) and acceptor (A) were 2.957 Å for N(2)–H(2)⋅⋅⋅N(4), 3.170 Å for N(2)–H(2)⋅⋅⋅O(1) and 2.613 Å for N(3)–H(3)⋅⋅⋅O(2), respectively. The N⋅⋅⋅Cl distances between donor (D) and acceptor (A) were 3.528 (6) Å for N(2)–H(3)⋅⋅⋅Cl(1), a weak hydrogen bond. Details of the hydrogen bonding in this crystal structure are listed in Table 3.

3.2. Spectroscopic Properties

The structure of Compound 1 was confirmed by 1H NMR, 13C NMR and HRMS analysis. In the 1H-NMR spectrum, one wide single peak with chemical shifts of δ 8.79 ppm exhibited the presence of N–H proton. The signals of the proton in the benzene ring were clearly discovered at δ 7.34–7.40 ppm. The protons of two methylene in the NHT ring and one methylene connected to the benzene ring were observed at 4.24 ppm and 3.78 ppm, respectively. The four methylene protons in 1,3,5-triazine ring had the same chemical shift. In the 13C NMR spectrum, the carbons of C2/C3 in NHT ring, C6/C10 and C7/C9 in benzene ring appeared as doublets at 59.58 ppm, 130.69 ppm and 128.44 ppm, respectively. The CH2 carbon C4 and the imino carbon C1 located the highest (53.25 ppm) and the lowest (155.80 ppm) field strength, respectively. The recorded HRMS spectral data of Compound 1 were in good accordance with the theoretical value.

3.3. Biological Activity

3.3.1. Aphicidal Activity

The aphicidal activity of Compound 1 and the positive control Pymetrozine against M. persicae, S. mischanthi, R. padi, S. graminum and M. dirhodum are shown in Table 4. The preliminary bioassay results (at a concentration of 200 mg/L, for 48 h) indicated that Compound 1 exhibited insecticidal activity against all of the tested aphid species. The aphicidal activities against M. persicae, R. padi and M. dirhodum were moderate, with inhibition rates of 58.5%, 63.5% and 51.0%, respectively. Its inhibition rates of S. mischanthi and S. graminum reached 74.1% and 77.5%. However, the aphicidal activities of Compound 1 were lower than that of commercial Pymetrozine. The structure of Compound 1 showed a partially similar features to neonicotinoids (Figure 3: 1, 2, 3 and 4 represent aromatic heterocycle, flexible linkage, electron-withdrawing group and hydro-heterocycles or guanidine/amidine, respectively). It contained parts 3 and 4, but did not contain parts 1 and 2. However, the structure of control Pymetrozine was screened from many compounds. It is highly effective against aphids via blockage of stylet resulting in irreversible stop of feed [51]. The structure property of Compound 1 might lead to lower aphicidal activity than commercial Pymetrozine. In the future, introduction of aromatic heterocycle on part 1 and flexible linkage on part 2 to the scaffold structure of Compound 1 are recommended. On the basis of the primary experimental results, aphid species exhibiting a mortality rate higher than 70% were chosen to determine the LC50 values. As shown in Table 5, Compound 1 exhibited a high aphicidal activity against S. miscanthi and S. graminum, with LC50 values of 47.8 mg/L and 33.6 mg/L, respectively. However, the aphicidal activities of Compound 1 were lower than Pymetrozine with LC50 values of 13.8 mg/L and 8.1 mg/L, respectively.

3.3.2. Antifungal Activity

The in vitro antifungal activity of Compound 1 against six plant fungal pathogens, R. solani, P. aphanidermatum, V. mali, B. cirerea, F. moniliforme and A. solani was estimated. The results are shown in Table 6. The data suggested that all compounds had weak to moderate antifungal activity. The preliminary bioassay indicated that Compound 1 exhibits weak inhibition activity towards R. solani, V. mali and F. moniliforme. Its inhibition rates of P. aphanidermatum, B. cirerea and A. solani reached 62.0%, 56.4% and 56.1% at 50 mg/L, respectively. Unfortunately, Compound 1 showed activities sometime comparable but usually lower activities for these plant fungal pathogens compared with the Difenoconazole control. However, these results indicated that Compound 1 could be further used as a lead compound to develop novel fungicides, particularly against P. aphanidermatum. Thus starting from lead Compound 1, further studies could be envisaged and searched by intermediate derivatization approach, an effective method for the discovery of new biologically active molecules [52], by introduction of active substructure or by synthesis of new analogues and reporting the structure activity relationships.

4. Conclusions

In summary, the compound, N-(5-(4-chlorobenzyl)-1,3,5-triazinan-2-ylidene)nitramide, has been prepared by Mannich reaction and characterized by 1H NMR, 13C NMR, HRMS and single-crystal x-ray structural determination. The biological activity results showed that the title compound, Compound 1, had favorable insecticidal activity against the aphids of S. miscanthi and S. graminum and exhibited moderate antifungal activities. The bioassay results demonstrate that this compound has a wide range of biological activities. This study offered valuable clues and will lay the foundation towards the design and synthesis of novel aphid control agents and fungicides.

Supplementary Materials

The following are available online at https://www.mdpi.com/2073-4352/10/4/245/s1, Table S1: Bond Lengths for Compound 1, Table S2: Bond angles for Compound 1, Table S3: Torsion angles for Compound 1, Table S4: Fractional atomic coordinates (×104) and equivalent isotropic displacement parameters (Å2 × 103) for Compound 1, Table S5: Anisotropic displacement parameters (Å2 × 103) for Compound 1, Table S6: Hydrogen atom coordinates (Å × 104) and isotropic displacement parameters (Å2 × 103) for Compound 1.

Author Contributions

Y.-G.Q. synthesized the crystalline material, carried out experimental work, analyzed the crystal data, conducted bioassays and wrote the manuscript; Z.-K.Y. helped in the NMR spectra analysis and the bioassay experiments; J.F. and X.J. helped in the bioassay experiments; J.-L.C., J.F., and X.-L.Y. supervised the entire study and revised the manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the National Natural Science Foundation of China (31801739 and 31871966), the National Key R & D Plan of China (2017YFD0200900, 2017YFD0201700, 2016YFD0300700 and 2017YFD0200504), China Postdoctoral Science Foundation (2018M631646) and the State Modern Agricultural Industry Technology System (CARS-22-G-18).

Acknowledgments

The authors would like to extend their sincere appreciation to Peking University and Beijing University of Chemical Technology for characterizing and analyzing of crystal structure.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Congreve, M.; Andrews, S.P.; Doré, A.S.; Hollenstein, K.; Hurrell, E.; Langmead, C.J.; Mason, J.S.; Ng, I.W.; Tehan, B.; Zhukov, A.; et al. Discovery of 1,2,4-triazine derivatives as adenosine A(2A) antagonists using structure based drug design. J. Med. Chem. 2012, 55, 1898–1903. [Google Scholar] [CrossRef] [PubMed]
  2. Irannejad, H.; Nadri, H.; Naderi, N.; Rezaeian, S.N.; Zafari, N.; Foroumadi, A.; Amini, M.; Khoobi, M. Anticonvulsant activity of 1,2,4-triazine derivatives with pyridyl side chain: Synthesis, biological, and computational study. Med. Chem. Res. 2015, 24, 2505–2513. [Google Scholar] [CrossRef]
  3. Kumar, R.; Roy, R.K.; Singh, A. 6(3,5-Substituted-2-bromo phenyl) 1,2,4-triazine derivatives as antimicrobial and anticancer agents. World J. Pharm. Pharmaceut. Sci. 2018, 7, 1316–1324. [Google Scholar]
  4. Zhang, T.Y.; Yu, Z.K.; Jin, X.J.; Li, M.Y.; Sun, L.P.; Zheng, C.J.; Piao, H.R. Synthesis and evaluation of the antibacterial activities of aryl substituted dihydrotriazine derivatives. Bioor. Med. Chem. Lett. 2018, 28, 1657–1662. [Google Scholar] [CrossRef] [PubMed]
  5. Koizumi, K.; Kuboyama, N.; Tomono, K.; Tanaka, A.; Ohki, A.; Kohno, H.; Wakabayashi, K.; Böger, P. Novel 1,3,5-triazine derivatives with herbicidal activity. Pestic. Manag. Sci. 2015, 55, 642–645. [Google Scholar] [CrossRef]
  6. Bakhite, E.A.; Abdella, A.A.; Elsayed, M.E.A.; Abdelraheem, S.A.A. Pyridine derivatives as insecticides. Part 1: Synthesis and toxicity of some pyridine derivatives against cowpea aphid, Aphis craccivora Koch (Homoptera: Aphididae). J. Agric. Food Chem. 2014, 62, 9982–9986. [Google Scholar] [CrossRef]
  7. Sun, C.W.; Wang, H.F.; Zhu, J.; Yang, D.R.; Jin, J.; Xing, J.H. Synthesis, insecticidal activities, and molecular docking studies of 1,5-disubstituted-1,3,5-hexahydrotriazine-2-(N-nitro)imines. J. Heterocycl. Chem. 2011, 48, 829–835. [Google Scholar] [CrossRef]
  8. Irvine, N.M.; Ricks, M.J.; Ross, R.; Bryan, K.; Klittich, C.J.R. Fungicidal 4-(2-aminopyridin-4-yl)-N-phenyl-1,3,5-triazin-2-amine. Derivatives. Patent WO 2005033095, 1 October 2004. [Google Scholar]
  9. Minn, K.; Ahrens, H.; Dietrich, H.; Wilims, L.; Auler, T.; Bieringer, H.; Menne, H. 2-Amino-4-bicyclyl amino-6H-1.3.5-triazines, Method for the Production and Use Thereof as Herbicides and Plant Growth. Regulators. Patent NZ 534737, 6 February 2003. [Google Scholar]
  10. Chen, H.; Huang, S.Q.; Xie, J.Y. Efficient synthesis of 2,4-dioxo-hexahydro-1,3,5-triazine O-acetyl-glycosyl glucosides and their antiviral activity. Chem. Heterocycl. Comp. 2009, 45, 976–980. [Google Scholar] [CrossRef]
  11. Sun, C.W.; Yang, D.Y.; Xing, J.H.; Wang, H.F.; Jin, J.; Zhu, J. Nitromethylene neonicotinoids analogues with tetrahydropyrimidine fixed cis-configuration: Synthesis, insecticidal activities, and molecular docking studies. J. Agric. Food Chem. 2010, 58, 3415–3421. [Google Scholar] [CrossRef]
  12. Maienfisch, P.; Kristiansen, O.; Gsell, L. Preparation of 2-(Nitroimino)-1,3,5-triazacyclohexane. Pesticides Patent EP 483055A1, 29 April 1992. [Google Scholar]
  13. Wu, K.; Kariya, A.; Katsuyama, N.; Tsuji, A.; Takasuka, K.; Segami, S.; Nanjo, K.; Sato, J. Hexahydrotriazine Compounds and Insecticides. U.S. Patent 6187773B1, 13 February 2001. [Google Scholar]
  14. Sun, C.W.; Zhu, J.; Wang, H.F.; Jin, J.; Xing, J.H.; Yang, D.R. Chiral 1,5-disubstituted 1,3,5-hexahydrotriazine-2-N-nitroimine analogues as novel potent neonicotinoids: Synthesis, insecticidal evaluation and molecular docking studies. Eur. J. Med. Chem. 2011, 46, 11–20. [Google Scholar] [CrossRef]
  15. Tsuboi, S.; Moriie, K.; Shibuya, K.; Sone, S.; Shiroshita, M. Preparation of Hexahydro-1,3,5-triazines as. Pesticides. Patent JP 04243876A, 31 August 1992. [Google Scholar]
  16. Maienfisch, P.; Huerlimann, H.; Rindlisbacher, A.; Gsell, L.; Dettwiler, H.; Haettenschwiler, J.; Sieger, E.; Walti, M. The discovery of thiamethoxam:a second-generation neonicotinoid. Pestic. Manag. Sci. 2001, 57, 165–176. [Google Scholar] [CrossRef]
  17. Grzegorz, G.; Dorota, C.; Jonathan, G.; Gawronski, S.W. Negative cross-resistance in triazine-resistant biotypes of Echinochloa crus-galli and Conyza Canadensis. Weed Sci. 2000, 48, 176–180. [Google Scholar]
  18. Saini, R.K.; Kleemann, S.G.L.; Preston, C.; Gill, G.S. Control of clethodim-resistant Lolium rigidum (rigid ryegrass) in triazine-tolerant canola (Brassica napus L.) in southern Australia. Crop Prot. 2015, 78, 99–105. [Google Scholar] [CrossRef]
  19. Gao, W.; Long, L.; Xu, L.; Lindsey, K.; Zhang, X.; Zhu, L. Suppression of the homeobox gene HDTF1 enhances resistance to Verticillium dahliae and Botrytis cinerea in cotton. J. Integr. Plant Biol. 2016, 58, 503–513. [Google Scholar] [CrossRef] [Green Version]
  20. Long, L.; Zhao, J.R.; Xu, F.C.; Yang, W.W.; Liao, P.; Gao, Y.; Gao, W.; Song, C.P. Silencing of GbANS reduces cotton resistance to Verticillium dahliae through decreased ROS scavenging during the pathogen invasion process. Plant Cell Tissue Organ Cult. 2018, 135, 213–221. [Google Scholar] [CrossRef]
  21. Qin, Y.G.; Zhang, J.P.; Song, D.L.; Duan, H.X.; Li, W.H.; Yang, X.L. Novel (E)-β-Farnesene analogues containing 2-nitroimino-hexahydro-1,3,5-triazine: Synthesis and biological activities evaluation. Molecules 2016, 21, 825. [Google Scholar] [CrossRef]
  22. Qin, Y.G.; Qu, Y.Y.; Zhang, J.P.; Tan, X.Q.; Song, L.F.; Li, W.H.; Song, D.L.; Yang, X.L. Synthesis and biological activity of different heterocyclic substituted (E)-β-Farnesene analogues. Chin. J. Org. Chem. 2015, 35, 455–461. [Google Scholar] [CrossRef]
  23. Du, S.Q.; Yang, Z.K.; Qin, Y.G.; Wang, S.S.; Duan, H.X.; Yang, X.L. Computational investigation of the molecular conformation-dependent binding mode of (E)-β-farnesene analogs with a heterocycle to aphid odorant-binding proteins. J. Mol. Model. 2018, 24, 70. [Google Scholar] [CrossRef]
  24. Shinde, R.S.; Salunke, S.D. Synthesis and studies of novel piperidine-substituted triazine derivatives as potential anti-inflammatory and antimicrobial agents. J. Chem. Pharm. Res. 2015, 7, 704–714. [Google Scholar]
  25. Vembu, S.; Pazhamalai, S.; Gopalakrishnan, M. Synthesis, spectral characterization, and effective antifungal evaluation of 1H-tetrazole containing 1,3,5-triazine dendrimers. Med. Chem. Res. 2016, 25, 1916–1924. [Google Scholar] [CrossRef]
  26. Dandia, A.; Arya, K.; Sati, M.; Sarawgi, P. Green chemical synthesis of fluorinated 1,3,5-triaryl-s-triazines in aqueous medium under microwaves as potential antifungal agents. J. Fluor. Chem. 2004, 125, 1273–1277. [Google Scholar] [CrossRef]
  27. Shiokawa, K.; Tsuboi, S.; Moriya, K.; Hattori, Y.; Honda, I.; Shibuya, K. Heterocyclic. Compounds Patent EP 386565A1, 9 December 1990. [Google Scholar]
  28. Sheldrick, G.M. Crystal structure refinement with SHELXL. Acta Cryst. 2015, C71, 3–8. [Google Scholar]
  29. Zhang, C.L.; Qu, Y.Y.; Wu, X.Q.; Song, D.L.; Ling, Y.; Yang, X.L. Eco-friendly insecticide discovery via peptidomimetics: Design, synthesis, and aphicidal activity of novel insect kinin analogues. J. Agric. Food Chem. 2015, 63, 4527–4532. [Google Scholar] [CrossRef] [PubMed]
  30. Qin, Y.G.; Zhang, J.P.; Song, D.L.; Duan, H.X.; Ling, Y.; Jiang, B.B.; Wang, D.; Yang, X.L. Design, synthesis and biological activity of novel aphid alarm pheromone analogues containing isonicotinic acid. Chem. J. Chin. Univ. 2016, 37, 1977–1986. [Google Scholar]
  31. Abbott, W.S. A method of computing of effectiveness of an insecticide. J. Econ. Entomol. 1925, 18, 265–267. [Google Scholar] [CrossRef]
  32. Sambandam, C.; Dhanavel, S.; Haridoss, M.; Mannuthusamy, G. Docking, synthesis, spectral characterization, and evaluation of in vitro antifungal activity of bis/monophenyl-1-aryl-1H-tetrazole-5-carboxylate. J. Heterocycl. Chem. 2019, 56, 2779–2786. [Google Scholar] [CrossRef]
  33. Zhang, J.P.; Li, X.Y.; Dong, Y.W.; Qin, Y.G.; Li, X.L.; Song, B.A.; Yang, X.L. Synthesis and biological evaluation of 4-methyl-1,2,3-thiadiazole-5-carboxaldehyde benzoyl hydrazine derivatives. Chin. Chem. Lett. 2017, 28, 1238–1242. [Google Scholar] [CrossRef]
  34. Xu, L.Z.; Yin, R.F.; Li, H.X. (E)-5-benzyl-1-methyl-N-nitro-1,3,5-triazinan-2-imine. Acta Cryst. 2010, 66, o867. [Google Scholar] [CrossRef] [Green Version]
  35. Zhao, C.; Yang, W.G.; Hu, Y.H.; Shen, L.; Lu, X.T. 1,5-Dimethyl-2-nitroimino-1,3,5-triazinane. Acta Cryst. 2008, 64, o1515. [Google Scholar] [CrossRef]
  36. Hu, Z.Q.; Yang, X.D.; An, G.W.; Yang, Z.; Xu, L.Z. 1-(2-Chloro-1,3-thiazol-5-ylmethyl)-3,5-dimethyl-2-nitrimino-1,2,3,4,5,6-hexahydro-1,3,5-triazine. Acta Cryst. 2008, 64, o121. [Google Scholar] [CrossRef]
  37. Bracuti, A.J. Crystal structure of 2-nitrimino-5-nitro-hexahydro-1,3,5-triazine. J. Chem. Crystallogr. 2004, 34, 135–140. [Google Scholar] [CrossRef]
  38. Deng, X.L.; Zhou, X.M.; Wang, Z.Y.; Rui, C.H.; Yang, X.L. Synthesis, crystal structure and insecticidal activity of N-(pyridin-2-ylmethyl)-1-phenyl-1,4,5,6,7,8-hexahydrocyclohepta[c]pyrazole-3-carboxamide. Chin. J. Struct. Chem. 2018, 37, 551–556. [Google Scholar]
  39. Zheng, W.N.; Zhu, Z.Y.; Deng, Y.N.; Wu, Z.C.; Zhou, Y.; Zhou, X.M.; Bai, L.Y.; Deng, X.L. Synthesis, crystal structure, herbicide safening, and antifungal activity of N-(4,6-dichloropyrimidine-2-yl)benzamide. Crystals 2018, 8, 75. [Google Scholar] [CrossRef] [Green Version]
  40. Mu, J.X.; Zhai, Z.W.; Yang, M.Y.; Sun, Z.H.; Wu, H.K.; Liu, X.H. Synthesis, crystal structure, DFT Study and antifungal activity of 4-(5-((4-bromobenzyl) thio)-4-phenyl-4H-1,2,4-triazol-3-yl)pyridine. Crystals 2016, 6, 4. [Google Scholar] [CrossRef] [Green Version]
  41. Zhao, Y.; Wang, G.; Li, Y.Q.; Wang, S.H.; Li, Z.M. Design, synthesis and insecticidal activities of novel N-oxalyl derivatives of neonicotinoid compound. Chin. J. Chem. 2010, 28, 475–479. [Google Scholar] [CrossRef]
  42. Fu, Z.D.; Su, R.; Wang, Y.; Wang, Y.F.; Zeng, W.; Xiao, N.; Wu, T.K.; Zhou, Z.M.; Chen, J.; Chen, F.X. Synthesis and characterization of energetic 3-nitro-1,2,4-oxadiazoles. Chem. Eur. J. 2012, 18, 1886–1889. [Google Scholar] [CrossRef]
  43. Zalewski, A.N.; Nathanael, J.G.; White, J.M.; Wille, U. Oxidation of cholesterol and O-protected derivatives by the environmental pollutant NO2. Chem. Commun. 2016, 52, 4060–4063. [Google Scholar] [CrossRef]
  44. López, Y.; Santillan, R.; Farfán, N. New bisfuran derivative from sarsasapogenin: An X-ray and NMR analysis. Steroids 2006, 71, 12–17. [Google Scholar] [CrossRef]
  45. López, Y.; Ruíz-Pérez, K.M.; Yépez, R.; Santillan, R.; Flores-Alamo, M.; Iglesias-Arteaga, M.A. Mechanistic insights and new products of the reaction of steroid sapogenins with NaNO2 and BF3·Et2O in acetic acid. Steroids 2008, 73, 657–668. [Google Scholar] [CrossRef]
  46. Cameron, T.S.; Cordes, R.E.; Morris, D.G.; Murray, A.M. Crystal and molecular structure of 4,N-dinitrobornan-2-imine (4,N-dinitrocamphorimine). J. Chem. Soc. Perkin Trans. 1979, 2, 300–303. [Google Scholar] [CrossRef]
  47. Ranise, A.; Bondavalli, F.; Schenone, P.; Mugnoli, A.; Panib, M. Synthesis and reactivity of (1S,4S,5S)-5-bromo-1,3,3-trimethyl-N-nitro-zoxabicyclo[2.2.2]octan-6-imine. X-Ray molecular structure and absolute configuration of E and Z isomers of (1S,4S)-5,5-dibromo-l,3,3-trimethyl-N-nitro-2-oxabicyclo[2.2.2]octan-6-imine, the first case of separated nitrimine isomers. J. Chem. Soc. Perkin Trans. 1990, 1, 3053–3059. [Google Scholar]
  48. Makhloufi, A.; Frank, W.; Ganter, C. Diamino- and mixed amino–amido-N-heterocyclic carbenes based on triazine backbones. Organometallics 2012, 31, 2001–2008. [Google Scholar] [CrossRef]
  49. Vujkovic, N.; César, V.; Lugan, N.; Lavigne, G. An ambidentate Janus-type ligand system based on fused carbene and imidato functionalities. Chem. Eur. J. 2011, 17, 13151–13155. [Google Scholar] [CrossRef] [PubMed]
  50. César, V.; Misal Castro, L.C.; Dombray, T.; Sortais, J.B.; Darcel, C.; Labat, S.; Miqueu, K.; Sotiropoulos, J.M.; Brousses, R.; Lugan, N.; et al. (Cyclopentadienyl)iron(II) complexes of N-heterocyclic carbenes bearing a malonate or imidate backbone: Synthesis, structure, and catalytic potential in hydrosilylation. Organometallics 2013, 32, 4643–4655. [Google Scholar] [CrossRef]
  51. Harrewijn, P.; Kayser, H. Pymetrozine, a fast-acting and selective inhibitor of aphid feeding. In-situ studies with electronic monitoring of feeding behavior. Pestic. Sci. 1997, 49, 130–140. [Google Scholar] [CrossRef]
  52. Guan, A.Y.; Liu, C.L.; Yang, X.P.; Dekeyser, M. Application of the intermediate derivatization approach in agrochemical discovery. Chem. Rev. 2014, 114, 7079–7107. [Google Scholar] [CrossRef]
Crystals 10 00245 sch001 550
Scheme 1. Synthetic approach of the title Compound 1.
Scheme 1. Synthetic approach of the title Compound 1.
Crystals 10 00245 sch001
Crystals 10 00245 g001 550
Figure 1. Crystal Structure of Compound 1.
Figure 1. Crystal Structure of Compound 1.
Crystals 10 00245 g001
Crystals 10 00245 g002 550
Figure 2. Hydrogen bonds (dashed lines) and crystal packing in Compound 1.
Figure 2. Hydrogen bonds (dashed lines) and crystal packing in Compound 1.
Crystals 10 00245 g002
Crystals 10 00245 g003 550
Figure 3. Structure features of neonicotinoids.
Figure 3. Structure features of neonicotinoids.
Crystals 10 00245 g003
Table
Table 1. Crystal data and structure refinement data of Compound 1.
Table 1. Crystal data and structure refinement data of Compound 1.
Compound1
CCDC No.1973548
Empirical formulaC10H12ClN5O2
Formula weight269.70
Temperature/K109.35
Crystal systemmonoclinic
Space groupP21/c
a/Å5.46593(17)
b/Å24.7334(6)
c/Å8.6800(3)
α/°90.00
β/°95.218(3)
γ/°90.00
Volume/Å31168.59(6)
Z4
ρcalcmg/mm31.533
µ/mm-10.330
F(000)560
Crystal size/mm30.36 × 0.20 × 0.14
2Θ range for data collection6.59 to 58.972°
Index ranges−7 ≤ h ≤ 7, −33 ≤ k ≤ 34, −7 ≤ l ≤ 11
Reflections collected9949
Independent reflections2794[R(int) = 0.0332, Rsigma = 0.0355]
Data/restraints/parameters2794/0/169
Goodness-of-fit on F21.066
Final R indexes [I > 2σ (I)]R1 = 0.0383, wR2 = 0.0814
Final R indexes [all data]R1 = 0.0468, wR2 = 0.0864
Largest diff. peak/hole / e Å−30.29/−0.29
Table
Table 2. Selected molecular structure parameters.
Table 2. Selected molecular structure parameters.
BondDistance (Å)BondDistance (Å)
Cl(1)–C(8)1.7538(15)N(3)–C(3)1.472(2)
O(1)–N(5)1.2459(17)N(4)–N(5)1.3405(17)
O(2)–N(5)1.2500(16)N(4)–C(1)1.3707(19)
N(1)–C(2)1.4476(18)C(4)–C(5)1.506(2)
N(1)–C(3)1.4453(19)C(5)–C(6)1.390(2)
N(2)–C(1)1.3310(19)C(5)–C(10)1.396(2)
N(2)–C(2)1.4743(19)C(7)–C(8)1.380(2)
N(3)–C(1)1.3277(19)C(8)–C(9)1.387(2)
Angle(˚)Angle(˚)
C(2)–N(1)–C(4)112.61(11)N(1)–C(2)–N(2)111.42(12)
C(3)–N(1)–C(2)108.67(12)N(1)–C(3)–N(3)111.35(12)
C(1)–N(2)–C(2)123.18(13)N(1)–C(4)–C(5)111.81(12)
C(1)–N(3)–C(3)119.53(13)C(6)–C(5)–C(10)118.68(14)
N(5)–N(4)–C(1)119.53(12)C(7)–C(6)–C(5)121.47(15)
O(1)–N(5)–O(2)121.48(12)C(8)–C(7)–C(6)118.35(14)
O(1)–N(5)–N(4)114.46(12)C(7)–C(8)–C(9)122.04(14)
N(3)–C(1)–N(2)119.06(14)C(8)–C(9)–C(10)118.62(15)
N(3)–C(1)–N(4)128.22(14)C(9)–C(10)–C(5)120.81(14)
Torsion(˚)Torsion(˚)
N(1)–C(4)–C(5)–C(10)–40.97(19)C(2)–N(2)–C(1)–N(3)6.7(2)
N(5)–N(4)–C(1)–N(2)–178.25(12)C(3)–N(1)–C(2)–N(2)–49.32(15)
C(1)–N(3)–C(3)–N(1)–35.90(18)C(3)–N(3)–C(1)–N(2)2.5(2)
C(1)–N(4)–N(5)–O(2)–3.4(2)C(3)–N(3)–C(1)–N(4)–177.22(14)
C(2)–N(1)–C(3)–N(3)58.45(15)C(6)–C(7)–C(8)–Cl(1)177.65(12)
C(2)–N(1)–C(4)–C(5)177.92(12)C(8)–C(9)–C(10)–C(5)1.4(2)
Table
Table 3. Hydrogen bonding interactions of Compound 1.
Table 3. Hydrogen bonding interactions of Compound 1.
D–H⋅⋅⋅Ad(D–H)/(Å)d(H⋅⋅⋅A)/(Å)d(D⋅⋅⋅A)/(Å)< (DHA)/(Å)
N(2)–H(2)⋅⋅⋅O(1)#10.8242.5703.170130.84
N(2)–H(2)⋅⋅⋅N(4)#20.8242.1362.957174.88
N(3)–H(3)⋅⋅⋅O(2)0.8082.0152.613130.42
N(3)–H(3)⋅⋅⋅Cl(1)#30.8082.9503.528130.42
Symmetry transformations used to generate equivalent atoms: #1: -x + 2, -y, -z + 2; #2: -x + 2, -y, -z + 2; #3: x, -y + 1/2, z + 1/2.
Table
Table 4. The in vivo aphicidal activity of Compound 1.
Table 4. The in vivo aphicidal activity of Compound 1.
CompoundInhibition Rates of Compounds at Concentration 200 mg/L (%)**
M. PersicaeS. MiscanthiR. PadiS. GraminumM. Dirhodum
158.5 ± 2.874.1 ± 2.263.5 ± 2.977.5 ± 1.851.0 ± 2.2
Pymetrozine*84.0 ± 3.692.3 ± 3.787.1 ± 3.589.5 ± 4.274.5 ± 4.0
* Pymetrozine was used as a positive control; ** Average of three replicates, mean ± sd.
Table
Table 5. The LC50 of Compound 1.
Table 5. The LC50 of Compound 1.
CompoundS. MiscanthiS. Graminum
LC50 (95% FL), mg/LToxic Regression EquationRLC50 (95% FL), mg/LToxic Regression EquationR
147.8 (37.2−61.0)y = 1.312x−2.2680.96933.6 (23.7−44.7)y= 0.924x−1.4110.903
Pymetrozine13.8 (8.3−19.2)y = 1.083x−1.2350.9528.1 (2.5−14.3)y= 0.738x−0.6710.939
Table
Table 6. The in vitro antifungal activity of Compound 1.
Table 6. The in vitro antifungal activity of Compound 1.
CompoundInhibition Rate of Compounds at Concentration 50 mg/L (%)
R. SolaniP. AphanidermatumV. MaliB. CirereaF. MoniliformeA. Solani
130.3 ± 0.862.0 ± 2.427.1 ± 2.156.4 ± 2.723.0 ± 1.256.1 ± 1.5
Difenoconazole80.2 ± 2.065.4 ± 0.9100.0 ± 0.083.8 ± 1.192.2 ± 1.783.1 ± 2.0

Share and Cite

MDPI and ACS Style

Qin, Y.-G.; Yang, Z.-K.; Fan, J.; Jiang, X.; Yang, X.-L.; Chen, J.-L. Synthesis, Crystal Structure and Bioactivities of N-(5-(4-chlorobenzyl)-1,3,5-Triazinan-2-Ylidene)Nitramide. Crystals 2020, 10, 245. https://doi.org/10.3390/cryst10040245

AMA Style

Qin Y-G, Yang Z-K, Fan J, Jiang X, Yang X-L, Chen J-L. Synthesis, Crystal Structure and Bioactivities of N-(5-(4-chlorobenzyl)-1,3,5-Triazinan-2-Ylidene)Nitramide. Crystals. 2020; 10(4):245. https://doi.org/10.3390/cryst10040245

Chicago/Turabian Style

Qin, Yao-Guo, Zhao-Kai Yang, Jia Fan, Xin Jiang, Xin-Ling Yang, and Ju-Lian Chen. 2020. "Synthesis, Crystal Structure and Bioactivities of N-(5-(4-chlorobenzyl)-1,3,5-Triazinan-2-Ylidene)Nitramide" Crystals 10, no. 4: 245. https://doi.org/10.3390/cryst10040245

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop